Carisma Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 107
- Market Cap
- $47.7M
- Introduction
Carmanah Minerals Corp is in the exploration stage company. It engages in the exploration and development of mineral properties in Canada. The projects in which the company holds an interest are Walker Project (Uranium), Hare Hill Project (Pluton), and Loljuh Project.
CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Carisma Therapeutics Inc
- Target Recruit Count
- 6
- Registration Number
- NCT06254807
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- HER2-positiveCarcinoma, HepatocellularLung Cancer, Non-Small-CellEsophagogastric Junction NeoplasmsInflammatory Breast CancerProstate CancerLung Cancer, Small CellBile Duct CancerCarcinoma, DuctalCancer
- Interventions
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Carisma Therapeutics Inc
- Target Recruit Count
- 48
- Registration Number
- NCT04660929
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
🇺🇸OHSU Knight Cancer Institute, Portland, Oregon, United States